about
Automaticity and conduction properties of bio-artificial pacemakers assessed in an in vitro monolayer model of neonatal rat ventricular myocytes.Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytesRaloxifene, tamoxifen and vascular tone.Synergistic effects of inward rectifier (I) and pacemaker (I) currents on the induction of bioengineered cardiac automaticity.ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system.Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway.Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent stateTherapeutically relevant concentrations of raloxifene dilate pressurized rat resistance arteries via calcium-dependent endothelial nitric oxide synthase activation.Exogenous expression of HIF-1 alpha promotes cardiac differentiation of embryonic stem cells.Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes.Raloxifene relaxes rat pulmonary arteries and veins: roles of gender, endothelium, and antagonism of Ca2+ influx.Overexpression of HCN-encoded pacemaker current silences bioartificial pacemakers.Cobalt chloride pretreatment promotes cardiac differentiation of human embryonic stem cells under atmospheric oxygen level.Regulation of cell proliferation of human induced pluripotent stem cell-derived mesenchymal stem cells via ether-à-go-go 1 (hEAG1) potassium channel.Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium.Raloxifene improves vascular reactivity in pressurized septal coronary arteries of ovariectomized hamsters fed cholesterol diet.Raloxifene modulates pulmonary vascular reactivity in spontaneously hypertensive rats
P50
Q34022401-BE3CBA23-6E5A-410C-9DF8-B868CF33CCEDQ35580463-87916135-49D8-4C5D-98DC-DED829DD9954Q36864691-9E31EDA8-D1B4-4986-AE75-8380AFC75646Q37336156-6B222D22-7EE5-4351-A574-A40A2C5CAC3FQ39653187-13B46B90-64D3-490A-A996-DA865460D3EEQ39674336-CEC3C88D-20A6-4B80-9DA1-60B4D0A58959Q39978595-AC66EDFA-E47C-47D9-B20C-798D2522E3CEQ43149018-D275EA47-F8C8-48B4-AA1F-E1A3234BD405Q43179970-0065BF9B-31EB-431B-8428-CD5A27AC4B50Q43438840-29F1CECE-0528-43F9-9EDB-816839C8BB80Q45154761-964976BA-1579-4901-9B70-F0186C92687EQ46521041-8F70A501-D8B9-4727-9443-73D25AF1378CQ48820420-68852BA2-DFF5-4738-969B-5E5FD1FF47D9Q50251918-26C804DD-3A04-4159-BE30-391099C1D44DQ50541458-2EA14D59-9120-43D8-AC84-CB14D77F6787Q51400979-82135A29-EF47-428B-977C-25B9516888B2Q80495986-D6DE3DFD-C089-4D2F-992C-2CC5942D077C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yau Chi Chan
@ast
Yau Chi Chan
@en
Yau Chi Chan
@es
Yau Chi Chan
@nl
Yau Chi Chan
@sl
type
label
Yau Chi Chan
@ast
Yau Chi Chan
@en
Yau Chi Chan
@es
Yau Chi Chan
@nl
Yau Chi Chan
@sl
prefLabel
Yau Chi Chan
@ast
Yau Chi Chan
@en
Yau Chi Chan
@es
Yau Chi Chan
@nl
Yau Chi Chan
@sl
P106
P1153
7403676116
P31
P496
0000-0003-0854-0506